Bradley J. Bolzon's most recent trade in CRISPR Therapeutics AG was a trade of 12,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 9, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 126.41 per share. | 19 Jul 2021 | 4,472 | 150,855 (0%) | 0% | 126.4 | 565,289 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 125.67 per share. | 19 Jul 2021 | 3,504 | 155,327 (0%) | 0% | 125.7 | 440,345 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 127.36 per share. | 19 Jul 2021 | 1,324 | 149,531 (0%) | 0% | 127.4 | 168,619 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 128.71 per share. | 19 Jul 2021 | 700 | 148,831 (0%) | 0% | 128.7 | 90,094 | Common Shares |
| Monte Rosa Therapeutics Inc | Bradley J. Bolzon | Director, Ten Percent Owner | 28 Jun 2021 | 20,004,280 | 0 | - | - | Series A convertible preferred stock | ||
| Monte Rosa Therapeutics Inc | Bradley J. Bolzon | Director, Ten Percent Owner | 28 Jun 2021 | 6,515,869 | 6,799,115 | - | - | Common Stock | ||
| Monte Rosa Therapeutics Inc | Bradley J. Bolzon | Director, Ten Percent Owner | 28 Jun 2021 | 4,150,000 | 0 | - | - | Series B convertible preferred stock | ||
| Monte Rosa Therapeutics Inc | Bradley J. Bolzon | Director, Ten Percent Owner | 28 Jun 2021 | 3,000,000 | 0 | - | - | Series B convertible preferred stock | ||
| Monte Rosa Therapeutics Inc | Bradley J. Bolzon | Director, Ten Percent Owner | 28 Jun 2021 | 2,699,328 | 0 | - | - | Series C convertible preferred stock | ||
| Monte Rosa Therapeutics Inc | Bradley J. Bolzon | Director, Ten Percent Owner | 28 Jun 2021 | 1,940,043 | 1,940,043 | - | - | Common Stock | ||
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 615,607 | 104,874 (0%) | 1% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 366,084 | 215,915 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 158,522 | 0 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 158,522 | 158,522 (0%) | 0% | 0 | Common Shares | |
| Monte Rosa Therapeutics Inc | Bradley J. Bolzon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 157,895 | 2,097,938 | - | 19 | 3,000,005 | Common Stock |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 84,085 | 0 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 79,074 | 79,074 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 27,861 | 16,434 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 27,716 | 27,716 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 18,973 | 46,689 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 150.49 per share. | 28 Jun 2021 | 12,753 | 7,846 (0%) | 0% | 150.5 | 1,919,237 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 12,189 | 6,268 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 148.58 per share. | 28 Jun 2021 | 12,176 | 28,580 (0%) | 0% | 148.6 | 1,809,095 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 11,011 | 5,614 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 149.47 per share. | 28 Jun 2021 | 7,981 | 20,599 (0%) | 0% | 149.5 | 1,192,915 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 151.24 per share. | 28 Jun 2021 | 6,646 | 1,200 (0%) | 0% | 151.2 | 1,005,162 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 151.49 per share. | 28 Jun 2021 | 6,403 | 10,756 (0%) | 0% | 151.5 | 970,022 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 6,018 | 0 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 6,018 | 6,018 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 147.43 per share. | 28 Jun 2021 | 4,780 | 40,756 (0%) | 0% | 147.4 | 704,725 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 153.54 per share. | 28 Jun 2021 | 4,519 | 3,098 (0%) | 0% | 153.5 | 693,842 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 3,650 | 622 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 150.65 per share. | 28 Jun 2021 | 3,216 | 17,159 (0%) | 0% | 150.7 | 484,491 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 151.49 per share. | 28 Jun 2021 | 3,144 | 164,109 (0%) | 0% | 151.5 | 476,300 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 152.38 per share. | 28 Jun 2021 | 3,139 | 7,617 (0%) | 0% | 152.4 | 478,309 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 2,633 | 84,085 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 2,378 | 81,452 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 154.57 per share. | 28 Jun 2021 | 2,281 | 817 (0%) | 0% | 154.6 | 352,564 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 153.54 per share. | 28 Jun 2021 | 2,218 | 160,351 (0%) | 0% | 153.5 | 340,549 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 150.65 per share. | 28 Jun 2021 | 1,578 | 167,253 (0%) | 0% | 150.7 | 237,726 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 152.38 per share. | 28 Jun 2021 | 1,540 | 162,569 (0%) | 0% | 152.4 | 234,660 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 145.92 per share. | 28 Jun 2021 | 1,400 | 46,136 (0%) | 0% | 145.9 | 204,284 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 152.42 per share. | 28 Jun 2021 | 1,200 | 0 (0%) | 0% | 152.4 | 182,906 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 154.57 per share. | 28 Jun 2021 | 1,119 | 159,232 (0%) | 0% | 154.6 | 172,959 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2021 | 847 | 47,536 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 146.69 per share. | 28 Jun 2021 | 600 | 45,536 (0%) | 0% | 146.7 | 88,016 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 156.54 per share. | 28 Jun 2021 | 549 | 0 (0%) | 0% | 156.5 | 85,941 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 156.54 per share. | 28 Jun 2021 | 269 | 158,831 (0%) | 0% | 156.5 | 42,110 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 155.27 per share. | 28 Jun 2021 | 268 | 549 (0%) | 0% | 155.3 | 41,613 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 155.27 per share. | 28 Jun 2021 | 132 | 159,100 (0%) | 0% | 155.3 | 20,496 | Common Shares |
| Black Diamond Therapeutics... | Bradley J. Bolzon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 133.28 per share. | 22 Mar 2021 | 9,334 | 35,912 (0%) | 0% | 133.3 | 1,244,070 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 132.53 per share. | 22 Mar 2021 | 6,090 | 45,246 (0%) | 0% | 132.5 | 807,092 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 134.33 per share. | 22 Mar 2021 | 5,237 | 30,675 (0%) | 0% | 134.3 | 703,495 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 129.36 per share. | 22 Mar 2021 | 3,600 | 57,149 (0%) | 0% | 129.4 | 465,678 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 130.42 per share. | 22 Mar 2021 | 3,413 | 53,736 (0%) | 0% | 130.4 | 445,112 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 131.14 per share. | 22 Mar 2021 | 2,400 | 51,336 (0%) | 0% | 131.1 | 314,741 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 134.93 per share. | 22 Mar 2021 | 300 | 30,375 (0%) | 0% | 134.9 | 40,478 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 01 Mar 2021 | 244,056 | 581,999 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 01 Mar 2021 | 56,056 | 0 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 01 Mar 2021 | 52,716 | 52,716 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 01 Mar 2021 | 18,574 | 44,295 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 01 Mar 2021 | 12,648 | 60,184 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 01 Mar 2021 | 8,126 | 18,457 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 01 Mar 2021 | 7,341 | 16,625 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 01 Mar 2021 | 4,012 | 0 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 01 Mar 2021 | 4,012 | 4,012 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 01 Mar 2021 | 1,755 | 56,056 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 01 Mar 2021 | 1,585 | 54,301 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 01 Mar 2021 | 565 | 60,749 (0%) | 0% | 0 | Common Shares | |
| Monte Rosa Therapeutics Inc | Bradley J. Bolzon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 2,699,328 | 2,699,328 | - | - | Series C convertible preferred stock | |
| Monte Rosa Therapeutics Inc | Bradley J. Bolzon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 2,075,000 | 4,150,000 | - | - | Series B convertible preferred stock | |
| Monte Rosa Therapeutics Inc | Bradley J. Bolzon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 1,500,000 | 3,000,000 | - | - | Series B convertible preferred stock | |
| Monte Rosa Therapeutics Inc | Bradley J. Bolzon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 47,132 | 47,132 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 615,607 | 720,481 (1%) | 1% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 366,084 | 826,055 (1%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 158,522 | 0 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 158,522 | 158,522 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 84,085 | 0 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 79,074 | 79,074 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 147.79 per share. | 19 Feb 2021 | 78,200 | 261,634 (0%) | 0% | 147.8 | 11,557,069 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 150.10 per share. | 19 Feb 2021 | 38,132 | 200,226 (0%) | 0% | 150.1 | 5,723,773 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 150.99 per share. | 19 Feb 2021 | 27,932 | 172,294 (0%) | 0% | 151.0 | 4,217,461 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 27,861 | 62,869 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 27,716 | 27,716 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 149.24 per share. | 19 Feb 2021 | 23,276 | 238,358 (0%) | 0% | 149.2 | 3,473,785 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 18,973 | 46,689 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 12,189 | 26,583 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 11,011 | 23,966 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 6,018 | 6,018 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 6,018 | 0 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 3,650 | 4,272 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 151.82 per share. | 19 Feb 2021 | 3,463 | 168,831 (0%) | 0% | 151.8 | 525,752 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 2,633 | 84,085 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 2,378 | 81,452 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 847 | 47,536 (0%) | 0% | 0 | Common Shares | |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 148.28 per share. | 16 Dec 2020 | 2,679 | 4,055 (0%) | 0% | 148.3 | 397,245 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 148.28 per share. | 16 Dec 2020 | 2,576 | 343,732 (0%) | 0% | 148.3 | 381,972 | Common Shares |
| CRISPR Therapeutics AG | Bradley J. Bolzon | Director | Sale of securities on an exchange or to another person at price $ 149.12 per share. | 16 Dec 2020 | 2,091 | 1,964 (0%) | 0% | 149.1 | 311,815 | Common Shares |